Etretinate

Etretinate is a lipid of Prenol Lipids (PR) class. Etretinate is associated with abnormalities such as Psoriasis, Skin lesion, Scleroderma, Chronic graft-versus-host disease and Evaluable Disease. The involved functions are known as Agent, Ulcer and Teratogenesis. Etretinate often locates in Hepatic and Skin. The related lipids are Steroids and Steroid, Systemic.

Cross Reference

Introduction

To understand associated biological information of Etretinate, we collected biological information of abnormalities, associated pathways, cellular/molecular locations, biological functions, related genes/proteins, lipids and common seen animal/experimental models with organized paragraphs from literatures.

What diseases are associated with Etretinate?

Etretinate is suspected in Scleroderma, Chronic graft-versus-host disease, Psoriasis, Skin lesion, Evaluable Disease, Pneumonia, Bacterial and other diseases in descending order of the highest number of associated sentences.

Related references are mostly published in these journals:

Disease Cross reference Weighted score Related literature
Loading... please refresh the page if content is not showing up.

No disease MeSH terms mapped to the current reference collection.

PubChem Associated disorders and diseases

What pathways are associated with Etretinate

There are no associated biomedical information in the current reference collection.

PubChem Biomolecular Interactions and Pathways

Link to PubChem Biomolecular Interactions and Pathways

What cellular locations are associated with Etretinate?

Related references are published most in these journals:

Location Cross reference Weighted score Related literatures
Loading... please refresh the page if content is not showing up.

What functions are associated with Etretinate?


Related references are published most in these journals:

Function Cross reference Weighted score Related literatures

What lipids are associated with Etretinate?

Related references are published most in these journals:

Lipid concept Cross reference Weighted score Related literatures
Loading... please refresh the page if content is not showing up.

What genes are associated with Etretinate?

There are no associated biomedical information in the current reference collection.

What common seen animal models are associated with Etretinate?

There are no associated biomedical information in the current reference collection.

NCBI Entrez Crosslinks

All references with Etretinate

Download all related citations
Per page 10 20 50 100 | Total 1071
Authors Title Published Journal PubMed Link
Török L et al. Bone-scintigraphic examinations in patients treated with retinoids: a prospective study. 1989 Br. J. Dermatol. pmid:2534736
Heule F et al. Three long-term regimens with cyclosporin for psoriasis vulgaris. 1989 Acta Derm Venereol Suppl (Stockh) pmid:2609861
Stosić-Grujicić S et al. In vitro effects of Ro 10-9359 on lectin-induced activation and proliferation of T lymphocytes. 1989 Acta Derm Venereol Suppl (Stockh) pmid:2609871
Mozzato MG et al. Red blood cell membrane cation transport in normotensive psoriatics. 1989 Acta Derm Venereol Suppl (Stockh) pmid:2609881
Trevisan G et al. Psoriatic microangiopathy modifications induced by PUVA and etretinate therapy. A nail-fold capillary microscopic study. 1989 Acta Derm Venereol Suppl (Stockh) pmid:2609884
Fléchet ML et al. [Subungual multiple keratoacanthoma]. 1989 Ann Dermatol Venereol pmid:2619190
Allen JG and Bloxham DP The pharmacology and pharmacokinetics of the retinoids. 1989 Pharmacol. Ther. pmid:2645583
Krari N et al. Effects of etretinate on the distribution of elements in rats. 1989 Biol Trace Elem Res pmid:2484224
Holland DB et al. Epidermal keratin levels during oral 1-alpha-hydroxyvitamin D3 treatment for psoriasis. 1989 Skin Pharmacol. pmid:2483330
Kuokkanen K [Retinoid treatment of pediatric skin diseases]. 1989 Duodecim pmid:2721405
Lucek RW et al. Pharmacokinetics of 14C-etretinate in healthy volunteers and two patients with biliary T-tube drainage. 1988 Sep-Oct Biopharm Drug Dispos pmid:3066416
Cappelletti V et al. Modulation of receptor levels in canine breast tumors by administration of tamoxifen and etretinate either alone or in combination. 1988 Nov-Dec Anticancer Res. pmid:3218961
Lestringant GG Tyrosinemia type II with incomplete Richner-Hanhart's syndrome. 1988 Jan-Feb Int. J. Dermatol. pmid:2964425
el Darouti MA et al. Papillon-Lefèvre syndrome. Successful treatment with oral retinoids in three patients. 1988 Jan-Feb Int. J. Dermatol. pmid:2964426
Patrizi A et al. [A case of harlequin fetus]. 1988 Jan-Feb G Ital Dermatol Venereol pmid:3417336
Bornemann LD et al. Effect of route of administration on the pharmacokinetics of etretinate in the dog. 1988 Jan-Feb Biopharm Drug Dispos pmid:2963666
Bird HA et al. A clinical and biochemical evaluation of etretinate in rheumatoid arthritis. 1988 Rheumatol. Int. pmid:3041545
Hopf G and Mathias B Teratogenicity of isotretinoin and etretinate. 1988 Lancet pmid:2903358
Thestrup-Pedersen K et al. Treatment of mycosis fungoides with recombinant interferon-alpha 2a2 alone and in combination with etretinate. 1988 Br. J. Dermatol. pmid:3042011
Weber U et al. Abnormal retinal function associated with long-term etretinate? 1988 Lancet pmid:2893053
Thongnopnua P and Zimmerman CL Biovailability and pulmonary first-pass removal of etretinate in rats. 1988 Res. Commun. Chem. Pathol. Pharmacol. pmid:3187194
McKerrow KJ et al. The effect of oral retinoid therapy on the normal human immune system. 1988 Br. J. Dermatol. pmid:2972309
Zachariae H Dangers of methotrexate/etretinate combination therapy. 1988 Lancet pmid:2893228
Shiohara T et al. Psoriasis occurring predominantly on warts. Possible involvement of interferon alfa. 1988 Arch Dermatol pmid:3190257
Brown RD and Grattan C Etretinate and vision. 1988 Lancet pmid:2894513
Carabott F et al. Etretinate-responsive pachyonychia congenita. 1988 Br. J. Dermatol. pmid:3191023
Lubach D and Kietzmann M Effects of treatment with dithranol, etretinate and a combination of dithranol and etretinate on epidermal metabolism and histology. Mouse tail assay. 1988 Arzneimittelforschung pmid:3196412
Rosén K Pustulosis palmoplantaris and chronic eczematous hand dermatitis. Treatment, epidermal Langerhans cells and association with thyroid disease. 1988 Acta Derm Venereol Suppl (Stockh) pmid:3285630
Halkier-Sørensen L and Andresen JH [Etretinate (Tigason) and bone changes]. 1988 Ugeskr. Laeg. pmid:3291352
Mori O et al. Effects of etretinate on epidermal Langerhans cell. 1988 Kurume Med J pmid:3251113
Hughes BR et al. Clinical response and tissue effects of etretinate treatment of patients with solar keratoses and basal cell carcinoma. 1988 J. Am. Acad. Dermatol. pmid:3280620
Lowe NJ et al. Etretinate. Appropriate use in severe psoriasis. 1988 Arch Dermatol pmid:3281595
Pardo RJ and Kerdel FA Hypertrophic lichen planus and light sensitivity in an HIV-positive patient. 1988 Int. J. Dermatol. pmid:3229890
Hans P et al. [Vertebral hyperostosis induced by etretinate]. 1988 Rev Rhum Mal Osteoartic pmid:3238301
Haake N and Altmeyer P [Vulvovaginitis circinata in Reiter's disease]. 1988 Hautarzt pmid:3243718
Wilson DJ et al. Skeletal hyperostosis and extraosseous calcification in patients receiving long-term etretinate (Tigason). 1988 Br. J. Dermatol. pmid:3207613
Darouti E and Rubaie A Psoriasis treatment with RePUVA in the United Arab Emirates. 1988 Int. J. Dermatol. pmid:3209324
Lammer EJ Embryopathy in infant conceived one year after termination of maternal etretinate. 1988 Lancet pmid:2903308
Embryopathy in infant conceived one year after termination of maternal etretinate: a reappraisal. 1988 Lancet pmid:2903985
Driban NE and Jung JR Treatment of Papillon-Lefèvre syndrome with etretinate. 1988 J. Am. Acad. Dermatol. pmid:2965168
Bussière JL and Ristori JM [Are retinoids active in the treatment of psoriatic rheumatism?]. 1988 Presse Med pmid:2965358
Winzer M and Wolff HH [Impetigo herpetiformis]. 1988 Hautarzt pmid:2966138
Menter A and Boyd A Cystic acne in psoriatic patients undergoing etretinate therapy. 1988 J. Am. Acad. Dermatol. pmid:2967312
Allegue Rodriguez F et al. [Treatment of erythrodermic and pustulous psoriasis with a combination of methotrexate and etretinate]. 1988 Med Cutan Ibero Lat Am pmid:2967409
Tosti A et al. Is etretinate dangerous in Papillon-Lefèvre syndrome? 1988 Dermatologica pmid:2967778
Jacyk WK and Bill PL Palmoplantar keratoderma with amyotrophy. 1988 Dermatologica pmid:2968285
Allan S and Christmas T Severe edema associated with etretinate. 1988 J. Am. Acad. Dermatol. pmid:2969923
Borbujo Martinez J et al. [Progressive symmetric erythrokeratodermia. Report of a case with delayed onset treated by etretinate]. 1988 Med Cutan Ibero Lat Am pmid:2974108
Bergman R and Friedman-Birnbaum R Papillon-Lefèvre syndrome: a study of the long-term clinical course of recurrent pyogenic infections and the effects of etretinate treatment. 1988 Br. J. Dermatol. pmid:2974305
Manuzzi P and Costa AM [Papillon-Lefèvre syndrome: spontaneous and therapeutically induced course in 2 clinical cases]. 1988 G Ital Dermatol Venereol pmid:2974835
Stallmann D and Schmoeckel C [Hailey-Hailey disease with dissemination and eczema herpeticatum in therapy with etretinate]. 1988 Hautarzt pmid:2975644
Rosińska D et al. Etretinate in severe psoriasis of children. 1988 Pediatr Dermatol pmid:2976495
Larrègue M et al. [Mendes Da Costa erythrokeratoderma variabilis. Effect of RO 10-9359 (Tigason)]. 1988 Ann Dermatol Venereol pmid:2977072
Larsen FG et al. Pharmacokinetics of etretin and etretinate during long-term treatment of psoriasis patients. 1988 Pharmacol. Toxicol. pmid:2967472
Rustin GJ et al. Treatment of advanced malignant melanoma with interferon alpha and etretinate. 1988 Eur J Cancer Clin Oncol pmid:3383979
Liang R Thrombocytopenia associated with etretinate therapy. 1988 Acta Haematol. pmid:3124469
Weber U et al. [Disorders of retinal function in long-term therapy with retinoid etretinate]. 1988 Klin Monbl Augenheilkd pmid:3145355
Seppälä J et al. Comparison of etretinate (Tigason) and parenteral gold in the treatment of psoriatic arthropathy. 1988 Clin. Rheumatol. pmid:3149925
Ashley JM et al. Fish oil supplementation results in decreased hypertriglyceridemia in patients with psoriasis undergoing etretinate or acitretin therapy. 1988 J. Am. Acad. Dermatol. pmid:2969924
Lowe NJ et al. Systemic retinoid therapy for psoriasis. 1988 J. Am. Acad. Dermatol. pmid:2970476
Gollnick H et al. Acitretin versus etretinate in psoriasis. Clinical and pharmacokinetic results of a German multicenter study. 1988 J. Am. Acad. Dermatol. pmid:2971692
Nishimura M et al. The effect of etretinate on plasma fibronectin in patients with vulgar psoriasis. 1988 J. Dermatol. pmid:3049737
Lassus A and Geiger JM Acitretin and etretinate in the treatment of palmoplantar pustulosis: a double-blind comparative trial. 1988 Br. J. Dermatol. pmid:2974306
de Groot AC and van der Schroeff JG [Skeletal abnormalities caused by etretinate]. 1988 Ned Tijdschr Geneeskd pmid:3054577
Yokota M and Mizuno N A case of lichen sclerosus et atrophicus of the vulva effectively treated with oral etretinate. 1988 J. Dermatol. pmid:3058762
Taube KM and Wozniak KD [Treatment of therapy resistant forms of psoriasis with etretinate. Case report]. 1988 Dermatol Monatsschr pmid:3169325
Jäger K [Side effects of etretinate therapy]. 1988 Dermatol Monatsschr pmid:3169329
David M et al. Electromyographic abnormalities in patients undergoing long-term therapy with etretinate. 1988 J. Am. Acad. Dermatol. pmid:3170793
Albin RL et al. A new syndrome of axial muscle rigidity associated with etretinate therapy. 1988 Mov. Disord. pmid:3173366
Lee SC et al. In vitro and in vivo regulation of transglutaminase activity of mouse epidermal cells by various vitamin A compounds. 1988 J. Dermatol. pmid:2906073
Higuchi M Electrophoretic mobility of polymorphonuclear leukocytes response to scale extracts from psoriasis vulgaris. 1988 J. Dermatol. pmid:3065379
Danno K et al. Etretinate treatment in disseminated porokeratosis. 1988 J. Dermatol. pmid:3065386
Thirumoorthy T and Shupack JL Adverse hepatic reactions associated with etretinate in patients with psoriasis--analysis of 22 cases. 1988 Ann. Acad. Med. Singap. pmid:3066276
Landow RK Etretinate. A clinician's view. 1988 Dermatol Clin pmid:3067916
Usuba S et al. [Distribution of nuclear DNase in psoriasis vulgaris and its changes after several therapies--a study of immunohistochemistry]. 1988 Nihon Hifuka Gakkai Zasshi pmid:3071635
Sassolas B et al. [Basal cell epitheliomatosis of the face in a man who had handled pitch]. 1988 Ann Dermatol Venereol pmid:3071965
Takashima A et al. Comparison of therapeutic efficacy of topical PUVA, oral etretinate, and combined PUVA and etretinate for the treatment of psoriasis and development of PUVA lentigines and antinuclear antibodies. 1988 J. Dermatol. pmid:3074090
Shuttleworth D et al. Treatment of cutaneous neoplasia with etretinate in renal transplant recipients. 1988 Q. J. Med. pmid:3076965
Marschalkó M et al. Etretinate for the treatment of lichen amyloidosis. 1988 Arch Dermatol pmid:3364990
Lubach D and Kietzmann M Effects of etretinate in epidermal metabolism and histology after abrasio of superficial layers. Mouse tail assay. 1988 Arzneimittelforschung pmid:3365278
Vardy D and Werner E [Combination of etretinate and dithrocream for severe psoriasis]. 1988 Harefuah pmid:3371786
Mensing H and Wagner G [Etretinate therapy in solitary keratoacanthomas]. 1988 Z. Hautkr. pmid:3388928
Richman TB and Kerdel FA Reiter's syndrome. 1988 Arch Dermatol pmid:3389840
Shuttleworth D and Marks R Congenital poikiloderma: treatment with etretinate. 1988 Br. J. Dermatol. pmid:3395568
Ciompi ML et al. Tigason (etretinate) treatment in psoriatic arthritis. 1988 Int J Tissue React pmid:3397251
Roydhouse N Retinoid therapy and anosmia. 1988 N. Z. Med. J. pmid:3399198
Dunn ML et al. Treatment options for psoriasis. 1988 Am J Nurs pmid:3400747
Halkier-Sørensen L Sexual dysfunction in a patient treated with etretinate. 1988 Acta Derm. Venereol. pmid:2449023
Kalamkarian AA et al. [Clinico-morphological variants and problems of therapy of Darier's keratosis follicularis]. 1988 Vestn Dermatol Venerol pmid:3414166
Abal'iants LA and Talanin NIu [Lewandowsky-Lutz epidermodysplasia verruciformis associated with vitiligo]. 1988 Vestn Dermatol Venerol pmid:3414173
Rosén K et al. Epidermal Langerhans' cells in patients with pustulosis palmoplantaris treated with etretinate or etretinate + methoxsalen photochemotherapy. 1988 Acta Derm. Venereol. pmid:2455414
Halkier-Sørensen L and Andresen J Etretinate and slender long bones in children. 1988 Acta Derm. Venereol. pmid:2455427
Wright AL et al. Self-healing epitheliomata of Ferguson-Smith: cytogenetic and histological studies, and the therapeutic effect of etretinate. 1988 Dermatologica pmid:3338600
Lowe NJ et al. Fish oil consumption reduces hypertriglyceridemia in psoriatic patients receiving etretinate therapy. 1988 Arch Dermatol pmid:3341796
Rowland Payne CM Etretinate and nodular prurigo. 1988 Br. J. Dermatol. pmid:3342173
Gold MH et al. The retinoids and inflammatory bowel disease. 1988 Arch Dermatol pmid:3345082
Schwengle LE and Rampen FH Eruptive seborrheic keratoses associated with erythrodermic pityriasis rubra pilaris. Possible role of retinoid therapy. 1988 Acta Derm. Venereol. pmid:2461032
Aram H Association of lichen planus and lichen nitidus. Treatment with etretinate. 1988 Int. J. Dermatol. pmid:3360550
Krause W Diagnosis of erectile dysfunction in etretinate treatment. 1988 Acta Derm. Venereol. pmid:2461037
Romppanen U et al. Serum levels of vitamin A, E, and selenium in women with lichen sclerosus of the vulva treated with etretinate. 1988 Gynecol. Obstet. Invest. pmid:3343023